317-622-8970 Back to results

No data

Toronto, Ontario

Toronto, Ontario, Canada50 employees$10.0M revenue
Visit Website

Products & Services

drug developmentdrugdevelopmentstrokeclinical trialsclinicaltrialspharmaceuticals

Company Description

NoNO Inc. Announces the Start of the Global Phase 3 ESCAPE-NEXT Trial of the Peptide Nerinetide in Acute Ischemic Stroke Excluding Thrombolysis

Business Contact Information

Phone
+1 (416) 603 - 5801
Fax
No data
Facebook
No data
Address
479 Wellington St W, Toronto, Ontario, M5V 1E7, Canada

Industry & Classification

Industry Name Level 1
No data
Industry Name Level 2
No data
Industry Name Level 3
No data
IndustryNo data

NAICS Codes

No data

SIC Codes

No data

Company Details

Employees
50
Annual Revenue
$10.0M
Established
No data
Total Funding
No data
Latest Funding
No data

Related Companies

Own this business?

Keep your profile accurate — or ask us to take it down. We acknowledge requests within 7 days and resolve them within 30 days.

Prefer email? privacy@facturmfg.com